We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,259 hedge funds and large institutions have $39.4B invested in Edwards Lifesciences in 2025 Q2 according to their latest regulatory filings, with 164 funds opening new positions, 423 increasing their positions, 458 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more first-time investments, than exits

New positions opened: 164 | Existing positions closed: 93

70% more call options, than puts

Call options by funds: $254M | Put options by funds: $149M

8% more capital invested

Capital invested by funds: $36.6B → $39.4B (+$2.79B)

5% more funds holding

Funds holding: 1,204 → 1,259 (+55)

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

0.57% less ownership

Funds ownership: 86.28% → 85.71% (-0.57%)

8% less repeat investments, than reductions

Existing positions increased: 423 | Existing positions reduced: 458

Holders
1,259
Holders Change
+55
Holders Change %
+4.57%
% of All Funds
16.58%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
164
Increased
423
Reduced
458
Closed
93
Calls
$254M
Puts
$149M
Net Calls
+$105M
Net Calls Change
+$25.1M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$359M
2
DZ Bank
DZ Bank
Germany
+$358M
3
Marshall Wace
Marshall Wace
United Kingdom
+$288M
4
Millennium Management
Millennium Management
New York
+$241M
5
Jennison Associates
Jennison Associates
New York
+$118M

Top Sellers

Rank Fund Capital Flow
1
Fisher Asset Management
Fisher Asset Management
Washington
-$730M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$694M
3
UBS AM
UBS AM
Illinois
-$396M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$120M
5
American Century Companies
American Century Companies
Missouri
-$78.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1201
Accent Capital Management
Ohio
$3.29K – – –
BLC
1202
Brown, Lisle/Cummings
Rhode Island
$3.29K – – –
T
1203
Transce3nd
Texas
$3.29K – – –
DWM
1204
Darwin Wealth Management
Florida
$3.28K – – –
WA
1205
WPG Advisers
Maryland
$3.21K +$298 +4 +11%
DPW
1206
DiNuzzo Private Wealth
Pennsylvania
$3.13K +$298 +4 +11%
SC
1207
Swan Capital
Florida
$3.07K – – –
BFP
1208
Briaud Financial Planning
Texas
$3K -$2.98K -40 -45%
PCM
1209
Penserra Capital Management
California
$3K – – –
LIM
1210
Longfellow Investment Management
Massachusetts
$2.97K – – –
FC
1211
Fairscale Capital
New Hampshire
$2.85K +$2.69K +36 New
HWP
1212
Highline Wealth Partners
California
$2.82K -$1.27K -17 -32%
FG
1213
Fairman Group
Pennsylvania
$2.82K – – –
FMB
1214
Field & Main Bank
Kentucky
$2.74K – – –
TFM
1215
TFC Financial Management
Massachusetts
$2.66K +$447 +6 +21%
IWM
1216
IMG Wealth Management
Florida
$2.66K +$2.54K +34 New
CIAS
1217
CBIZ Investment Advisory Services
Ohio
$2.5K +$2.39K +32 New
HFM
1218
Hartford Financial Management
Connecticut
$2.35K – – –
BWL
1219
Bogart Wealth LLC
Virginia
$2.27K -$75.4K -1,011 -97%
SC
1220
Stephens Consulting
Michigan
$2.19K +$2.09K +28 New
CTWM
1221
Cherry Tree Wealth Management
Minnesota
$2.03K -$8.65K -116 -82%
PWA
1222
Principia Wealth Advisory
Texas
$2.03K +$1.12K +15 +136%
NWM
1223
Nova Wealth Management
Florida
$2K +$1.94K +26 New
CMP
1224
Coston McIsaac & Partners
Maine
$2K – – –
WA
1225
WestEnd Advisors
North Carolina
$1.96K +$224 +3 +14%
47 48
49
50 51

EW Hedge Fund Activity: Q2 2025 in Review

1,259 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2025, worth a combined $39.4B — up 7.6% from $36.6B a quarter earlier.

Buyers outnumbered sellers: 164 funds opened new EW positions and 93 closed out — a net gain of 71 holders — while 423 added to existing stakes and 458 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $359M. The largest seller was Fisher Asset Management, cutting an estimated $730M.

  • 1,259 institutional investors held Edwards Lifesciences (EW) as of Q2 2025, up from 1,204 in Q1 2025.
  • Funds reported $39.4B of Edwards Lifesciences stock for Q2 2025, up 7.6% quarter-over-quarter.
  • 164 funds opened new Edwards Lifesciences positions in Q2 2025 and 93 closed out, a net change of +71 holders.
  • The largest Edwards Lifesciences buyer in Q2 2025 was JP Morgan Chase, an estimated $359M added.
  • The largest Edwards Lifesciences seller in Q2 2025 was Fisher Asset Management, an estimated $730M sold.

Based on aggregated 13F filings for Q2 2025.